Tech Company Financing Transactions
Fore Biotherapeutics Funding Round
On 5/23/2025, Fore Biotherapeutics secured $38 million in Series D financing from 3B Future Health Fund, Cormorant Asset Management and HBM Healthcare Investments.
Transaction Overview
Company Name
Announced On
5/23/2025
Transaction Type
Venture Equity
Amount
$38,000,000
Round
Series D
Investors
Proceeds Purpose
The company intends to use the funds to advance the registration-intended Forte Master Protocol, a global Phase 2 clinical trial which includes four sub-protocol baskets evaluating plixorafenib in distinct patient populations.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3675 Market Street 200
Philadelphia, PA 19104
USA
Philadelphia, PA 19104
USA
Phone
Website
Email Address
Overview
We are a precision oncology company using functional genomics to pioneer treatments that improve the lives of patients with rare cancers. Fore Bio is a next-generation precision oncology company. Using our functional genomics platform, we are hyper-targeting therapies to unaddressed tumor mutations to benefit patients with few therapeutic alternatives. Our mission is to provide "1-to-1" matching between patients and new treatments tailored to them and providing broad access with speed and quality.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthew Ros
Chief Financial Officer
Jeff Sacher
Chief Medical Officer
Stacie Shepherd
Chief Technical Officer
Gabi Tarcic
Browse more venture capital transactions:
Prev: 5/23/2025: Skriber venture capital transaction
Next: 5/23/2025: Veltist venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs